Clinical Trial Update: Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing adefovir dipivoxil in Chinese patients with compensated chronic hepatitis B; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2009-10-02